Clinical Pharmacology-Informed Development of COVID-19 Therapeutics: Regulatory Experience

Clin Pharmacol Ther. 2021 Apr;109(4):810-812. doi: 10.1002/cpt.2210. Epub 2021 Mar 14.

Authors

Su-Young Choi¹, Vikram Arya¹, Kellie Reynolds¹

Affiliation

¹ Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.

No abstract available

MeSH terms

Antiviral Agents / administration & dosage
Antiviral Agents / therapeutic use*
COVID-19 Drug Treatment*
Dose-Response Relationship, Drug
Drug Therapy, Combination
Evidence-Based Medicine
Humans
Microbiological Techniques
Pharmacology, Clinical / organization & administration*
Pharmacology, Clinical / standards
SARS-CoV-2

Substances

Antiviral Agents